Effectiveness, Safety, and Health-Related Outcomes of NUEDEXTA® in Nursing Home Patients With Pseudobulbar Affect (PBA)

Stopped early · Phase 4

Conditions studied: Pseudobulbar Affect (Involuntary Laughing and/or Crying)

In brief

6 month study of NUEDEXTA ® (Dextromethorphan Hydrobromide and Quinidine Sulfate) for the treatment of Pseudobulbar Affect (PBA) in Nursing Home Patients.

Key facts

Study ID
NCT02496039
Run by
Avanir Pharmaceuticals
People needed
5
Starts
2015-09-01
Expected to finish
2016-05-01
Last updated by the study team
2017-07-03

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.